Impact of Postapproval Evidence Generation on the Biopharmaceutical Industry-Reference-Cited by-同舟云学术

Impact of Postapproval Evidence Generation on the Biopharmaceutical Industry

Published:2015-08 Issue:8 Volume:37 Page:1852-1858
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Milne Christopher-Paul,Cohen Joshua P.,Felix Abigail,Chakravarthy Ranjana

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference16 articles.

1. Booz & Company. Pharmaceutical Sales and Marketing Trends 2011. February 2012. http://www.booz.com/media/file/BoozCo-Pharmaceutical-Sales-Marketing-Trends-National-Analysts-2011.pdf. Accessed March 1, 2015

2. Avalere Health. Delivering value in healthcare: a multi-stakeholder vision for innovation. Washington, DC: Avalere Health LLC. 2013

3. Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development;Schneeweiss;J Clin Pharmacol Ther,2011

4. Pragmatic Clinical Trials: US Payers’ Views on Their Value;Ratner;Am J Managed Care,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis;JAMA Neurology;2022-02-01

2. Strengths and weaknesses of ‘real-world’ studies involving non-vitamin K antagonist oral anticoagulants;Open Heart;2018-04

3. The Role of Noncomparative Evidence in Health Technology Assessment Decisions;Value in Health;2017-12

4. Impact of Comparative Effectiveness Research on Drug Development Strategy and Innovation;Decision Making in a World of Comparative Effectiveness Research;2017

5. The mixed randomized trial: combining randomized, pragmatic and observational clinical trial designs;Journal of Comparative Effectiveness Research;2016-11